Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1988-3-25
pubmed:abstractText
Six strains of Neisseria gonorrhoeae were distributed to 411 United Kingdom laboratories who were asked to test the susceptibility of the strains to penicillin, cefuroxime, tetracycline and spectinomycin and to test for production of beta-lactamase. Details of methods used were requested by means of a questionnaire. The number of reports recording sensitive strains as resistant was 5% for penicillin, 0.7% for cefuroxime, 3% for tetracycline and 4% for spectinomycin. The number of reports recording resistant strains as sensitive was 7% for penicillin (0.2% with beta-lactamase producing strains, 20% with non-beta-lactamase producing strains), 96% for cefuroxime, 76% for tetracycline and 8% for spectinomycin. There was an association between greater error rates and the use of high content discs for testing tetracycline, the use of low content discs for testing spectinomycin, failure to dilute the inoculum, and use of acidimetric methods rather than methods that use a chromogenic cephalosporin for detecting beta-lactamase.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-158836, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-3080532, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-3160647, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-3489739, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-3934128, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-4578213, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6129464, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6237711, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6441276, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6461702, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6681617, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6699195, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6817704, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6821501, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-6997258, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-7061722, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-7142426, http://linkedlifedata.com/resource/pubmed/commentcorrection/2963836-72244
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-9746
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
97-102
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Antimicrobial susceptibility testing of Neisseria gonorrhoeae: a trial organised as part of the United Kingdom national external quality assessment scheme for microbiology.
pubmed:affiliation
Division of Microbiological Reagents and Quality Control, Central Public Health Laboratory, Colindale, London.
pubmed:publicationType
Journal Article